Menu
GeneBe

rs374349989

Variant summary

Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1_ModeratePM2PP3_StrongPP5_Very_Strong

The NM_024809.5(TCTN2):c.1506-2A>G variant causes a splice acceptor change. The variant allele was found at a frequency of 0.0000205 in 1,608,974 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000021 ( 0 hom. )

Consequence

TCTN2
NM_024809.5 splice_acceptor

Scores

3
3
1
Splicing: ADA: 1.000
2

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:10

Conservation

PhyloP100: 5.98
Variant links:
Genes affected
TCTN2 (HGNC:25774): (tectonic family member 2) This gene encodes a type I membrane protein that belongs to the tectonic family. Studies in mice suggest that this protein may be involved in hedgehog signaling, and essential for ciliogenesis. Mutations in this gene are associated with Meckel syndrome type 8. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 16 ACMG points.

PVS1
Splicing variant, NOT destroyed by nmd, known LOF gene, truncates exone, which is 0.05062082 fraction of the gene. Cryptic splice site detected, with MaxEntScore 4, offset of -48, new splice context is: ttcactggaaatgactttAGgac. Cryptic site results in inframe change. If cryptic site found is not functional and variant results in exon loss, it results in frameshift change.
PM2
Very rare variant in population databases, with high coverage;
PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF, max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
PP5
Variant 12-123699702-A-G is Pathogenic according to our data. Variant chr12-123699702-A-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 31076.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-123699702-A-G is described in Lovd as [Pathogenic]. Variant chr12-123699702-A-G is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TCTN2NM_024809.5 linkuse as main transcriptc.1506-2A>G splice_acceptor_variant ENST00000303372.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TCTN2ENST00000303372.7 linkuse as main transcriptc.1506-2A>G splice_acceptor_variant 1 NM_024809.5 P4Q96GX1-1

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152110
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000159
AC:
4
AN:
251140
Hom.:
0
AF XY:
0.0000221
AC XY:
3
AN XY:
135806
show subpopulations
Gnomad AFR exome
AF:
0.0000618
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000213
AC:
31
AN:
1456864
Hom.:
0
Cov.:
31
AF XY:
0.0000221
AC XY:
16
AN XY:
725018
show subpopulations
Gnomad4 AFR exome
AF:
0.0000900
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000117
Gnomad4 OTH exome
AF:
0.0000499
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152110
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74338
show subpopulations
Gnomad4 AFR
AF:
0.0000483
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000478
Hom.:
0
Bravo
AF:
0.0000378
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.0000165
AC:
2
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:4
Pathogenic, criteria provided, single submitterclinical testingGeneDxFeb 25, 2022Canonical splice site variant in a gene for which loss-of-function is a known mechanism of disease; Published functional studies demonstrate that normal splicing is abolished and two abberant transcripts are created (Shaheen et al., 2011); Not observed at a significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 21462283, 26729329, 23169490, 31428121, 32055034, 31589614, 32552793) -
Pathogenic, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenSep 01, 2023TCTN2: PVS1, PM2 -
Pathogenic, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jul 14, 2017- -
Pathogenic, criteria provided, single submitterclinical testingRevvity Omics, RevvityJan 19, 2023- -
Meckel-Gruber syndrome;C0431399:Familial aplasia of the vermis Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingInvitaeDec 25, 2023This sequence change affects an acceptor splice site in intron 13 of the TCTN2 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in TCTN2 are known to be pathogenic (PMID: 21565611). This variant is present in population databases (rs374349989, gnomAD 0.008%). Disruption of this splice site has been observed in individual(s) with clinical features of TCTN2-related conditions (PMID: 21462283, 31428121). ClinVar contains an entry for this variant (Variation ID: 31076). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Joubert syndrome 24 Pathogenic:1
Pathogenic, criteria provided, single submitterresearchCenter for Genomic Medicine, King Faisal Specialist Hospital and Research CenterMar 17, 2024- -
Meckel syndrome, type 8 Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMJun 01, 2011- -
TCTN2-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017The TCTN2 c.1506-2A>G variant occurs in a canonical splice site (acceptor) and is therefore predicted to disrupt or distort the normal gene product. The c.1506-2A>G variant has been reported in three studies in which it is found in a homozygous state in at least six patients and in a heterozygous state in one patient in whom a second variant was not identified (Shaheen et al. 2011; Shaheen et al. 2013; Watson et al. 2016). Three of the homozygotes were diagnosed with Meckel syndrome and three patients were noted to be on the Joubert-Meckel syndrome spectrum but the individual clinical phenotypes were not provided (Watson et al. 2016). The c.1506-2A>G variant was absent from at least 192 controls and is reported at a frequency of 0.00012 in the European-American population of the Exome Sequencing Project but this is based on one allele only. RT-PCR experiments showed the variant completely abolished normal splicing and created two aberrant transcripts (Shaheen et al. 2011). Based on the evidence, the c.1506-2A>G variant is classified as pathogenic for TCTN2-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. -
Joubert syndrome and related disorders Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpFeb 12, 2024Variant summary: TCTN2 c.1506-2A>G is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: Four predict the variant abolishes a 3' acceptor site. At least one publication reports experimental evidence confirming that this variant affects mRNA splicing (Maddirevula_2020). The variant allele was found at a frequency of 1.6e-05 in 251140 control chromosomes (gnomAD). c.1506-2A>G has been reported in the literature in multiple individuals affected with Joubert Syndrome And Related Disorders (e.g. Shaheen_2016, Maddirevula_2020, Watson_2016). These data indicate that the variant is very likely to be associated with disease. ClinVar contains an entry for this variant (Variation ID: 31076). Based on the evidence outlined above, the variant was classified as pathogenic. -
Meckel syndrome, type 6 Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingPathology and Clinical Laboratory Medicine, King Fahad Medical City-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.49
D
BayesDel_noAF
Uncertain
0.020
Cadd
Uncertain
25
Dann
Uncertain
0.98
Eigen
Pathogenic
0.93
Eigen_PC
Pathogenic
0.73
FATHMM_MKL
Uncertain
0.95
D
MutationTaster
Benign
1.0
D;D
GERP RS
5.9

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.87
SpliceAI score (max)
1.0
Details are displayed if max score is > 0.2
DS_AL_spliceai
1.0
Position offset: 2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs374349989; hg19: chr12-124184249; API